PLS
Oxford PharmaGenesis is global, award winning and independent. Our unique HealthScience approach uses proven behaviour change techniques to maximize the impact of your communications and to ensure they resonate with the target audience. Talk to us to learn how we can help you improve collaboration, innovation, and strategy and planning.
Read More
Oxford PharmaGenesis has enjoyed another great year of bringing success for clients. From innovative studies to employee milestones, to a prestigious King’s Award, here is a round-up of our top highlights and most viewed headlines of the year. Read on to find out what we have been up to in 2023, and if you are […]
Read More
Oxford PharmaGenesis joins with local businesses to make Oxfordshire a better place to live and work
Oxford PharmaGenesis has joined the Oxfordshire Collective Business Fund, a way for the UK county’s local companies to make a genuine difference to communities by investing in local charitable organizations. Hosted by the Oxfordshire Community Foundation (OCF), a charity that builds thriving communities through effective philanthropy, the fund brings together Oxfordshire companies keen to be […]
Read More
This year’s Medical Affairs Professionals of Australasia (MAPA) and Medical Affairs Professional Society (MAPS) Medical Affairs Summit was held from 8 to 10 November 2023 in Sydney, Australia.
Read More
Congratulations to Oxford PharmaGenesis colleagues who were named Medical Affairs Communications Team of the Year at the PharmaTimes gala dinner and awards ceremony on Thursday 16 November!
Read More
Oxford PharmaGenesis, Oxford Health Policy Forum and MS Australia are celebrating the shortlisting of MS Brain Health for a PRIME Award for Sustained Excellence, and are incredibly proud to have been highly commended at the award ceremony. The awards took place in Sydney, Australia, on Thursday 9 November 2023. The PRIME Awards recognize and celebrate […]
Read More
Oxford PharmaGenesis is proud to sponsor a global consultation, run by Healthcare Information For All (HIFA) in partnership with the World Health Organization (WHO), to accelerate progress towards universal access to reliable healthcare information. Every day, tens of thousands of children and adults die needlessly for want of simple, low-cost interventions, which are often locally […]
Read More
HEOR and market access are evolving, with big changes in HTA around the corner, acceleration in the use of RWE and increased reactions to cost-containment measures. We are contributing to conversations about how these changes affect value demonstration strategies. At Oxford PharmaGenesis, we are experts in advising on payer strategy, developing payer evidence and supporting payer evaluation. We understand differences in payer evidence needs, and we know how to create compelling value stories for our clients that achieve powerful results.
Read More
Many scientific and medical publications lie behind a paywall. New medical research is increasingly being published as ‘open access’, which makes articles freely available to anyone. This provides major benefits because it gives researchers and members of the public equal access to medical knowledge. It also improves research transparency, which helps to foster public trust.
Read More
More than 150 medical publications professionals gathered in Philadelphia on 28–29 September 2023 for the inaugural ISMPP Academy. Oxford PharmaGenesis was a key event sponsor and we were delighted to give two valuable presentations to help attendees to explore new frontiers in publications. In line with the ISMPP Academy theme ‘PREP! Practical Resources to Elevate […]
Read More